<DOC>
	<DOCNO>NCT01322100</DOCNO>
	<brief_summary>Because electrochemotherapy quick effective treatment cutaneous metastasis , novel electrode device develop treatment soft tissue brain . Up 18 patient treated phase I dose-escalating study electrochemotherapy brain metastasis . Primary endpoint clinical trial safety secondary endpoint efficacy . One brain metastasis treat once-only electrode device guide stereotactically burr hole use CT monitoring . The patient fully anesthetize treatment procedure . Patients follow 6 month regard neurological function , Barthel Index , steroid use adverse effect registration ( CTCAE ) . Tumor response evaluate Magnetic Resonance imaging ( MRI ) .</brief_summary>
	<brief_title>Electrochemotherapy Palliative Treatment Brain Metastases</brief_title>
	<detailed_description>Electrochemotherapy cancer treatment modality comprise combination electrical pulse deliver electrode chemotherapy supply either intravenously intratumorally . It quick effective treatment cutaneous metastasis &lt; 3 cm complete response rate 73 % once-only treatment . The available electrode device far applicable cutaneous tumor . An electrode develop collaboration medico-technical company . An increase number cancer patient suffer metastasis brain due e.g . good control systemic peripheral cancer disease . The prognosis patient brain metastasis remain poor research new treatment need field . Up 18 patient treat dose-escalating study electrochemotherapy brain metastasis . Primary endpoint clinical trial safety secondary endpoint efficacy . One brain metastasis treat once-only electrode device guide stereotactically burr hole use CT monitoring . The patient fully anesthetize treatment procedure . Patients follow 6 month regard neurological function , Barthel Index , steroid use adverse effect registration ( CTCAE ) . Tumor response evaluate Magnetic Resonance imaging ( MRI ) . The first 6 patient receive intravenous dose bleomycin 15.000 IE/m2 electric pulse . The following patient receive additional intratumoral injection bleomycin increase concentration . The electrical pulse consist series high voltage pulse 0.1 millisecond duration .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Patients &gt; 18 year . Performance status &lt; 2 ( ECOG Eastern Cooperative Oncology Group ) . Diagnosis brain metastasis originate histological cytological verify cancer histology . Patients receive wholebrain radiation therapy ( WBRT ) time interval least 2 month completion WBRT inclusion study . Patients must offer every available standard treatment . Brain metastasis treat must diameter least 10 millimetre 27 millimetre . Brain metastasis treat must accessible treatment . Estimated life expectancy must 3 month . Patients must adequate organ function : Adequate bone marrow reserve : Leucocytes ( WBC ) &gt; 3.0 x 109/l , thrombocytes &gt; 75 x 109/l , hemoglobin &gt; 7 g/dl . Hepatic : Alkaline phosphate , ALAT ASAT bilirubin must increase 2 time , pp &gt; 40 , APTT normal range . Medical correction allow , e.g . correction low pp use vitamin K. Renal : creatinin &gt; 150 micromolar GFR examination ( ChromeEDTA ) . Patients must blood pressure ( BP ) 180 mm Hg systolic 110 mm Hg diastolic . Sexually active men woman childbearing potential must use adequate birth control study 6 month administration bleomycin ( contraceptive pill , intrauterine device , injection prolong gestagen , subdermal implantation , hormonal vaginal device , transdermal patch ) . Participating patient must able understand patient information . Participating patient must sign write inform consent power attorney prior inclusion study . Acute lung infection . Previous bleomycin treatment 200.000 IU/m2 . Previous allergic reaction bleomycin . Allergy towards sedation use . Pregnancy breastfeed . Pregnancy fertile woman exclude measurement HCG blood sample . Sterile infertile woman exclude requirement use anticonception . To consider sterile infertile , patient must undergo surgical sterilization ( vasectomy/bilateral tubectomy , hysterectomy bilateral ovariectomy ) postmenopausal define absence menstruation . Treatment GCSF ( Granulocyte Colony Stimulating Factor ) cytokine . Lung diffusion capacity ( DLCO ) normal . DLCO perform case suspect ( anamnestic clinical ) reduce lung function . Physician 's assessment meningeal carcinomatosis ( leptomeningeal disease ) likely cause patient 's symptom . Treatment anticoagulant ( marevan , marcumar , innohep ) . Allergic nickel , chrome cobalt . Participation another clinical study experimental drug 4 week prior inclusion . Illnesses , medical , social physiological , may affect patient 's ability understand patient information participate followup . Other serious systemic illness ( i.e . active infection , abnormal EKG ) investigator find may affect patient 's safety and/or ability complete study . Treatment Immunosuppressant drug methotrexate cyclosporine study . Treatment prednisolone accept study . Implanted pacemaker , defibrillator hearth valve prosthetics . Implanted device neurostimulators , eartransplants , insulinpump , metallic tracheostomy . Catheters metal Port รก cath , Swan Ganz , Pdialysis cath. , ventriculoatrial peritoneal shunt , bladder cath . thermomeasurement . Metallic clips/prosthetics/magnets surgery neuro abdominal clip , tooth prosthetics . Disorganised metallic material metal fragment eye , shrapnel , gun shot injury .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Brain Metastases , CNS Metastases</keyword>
</DOC>